Patient persistency with topical ocular hypotensive therapy in a managed care population
Authors:
- Gregory ReardonGRGregory Reardon
- Gail F SchwartzGSGail F Schwartz
- Essy MozaffariEMEssy Mozaffari
- 1 January 2004
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 137 (1) , S3-S12
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle sizeAmerican Journal of Ophthalmology, 2004
- Patient Persistency with Pharmacotherapy in the Management of GlaucomaEuropean Journal of Ophthalmology, 2003
- Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective studyClinical Therapeutics, 2003
- Factors for Glaucoma Progression and the Effect of TreatmentArchives of Ophthalmology (1950), 2003
- Reduction of Intraocular Pressure and Glaucoma ProgressionArchives of Ophthalmology (1950), 2002
- The Ocular Hypertension Treatment StudyArchives of Ophthalmology (1950), 2002
- The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deteriorationAmerican Journal of Ophthalmology, 2000
- Survival probabilities (the Kaplan-Meier method)BMJ, 1998
- Continuation of initial antihypertensive medication after 1 year of therapyClinical Therapeutics, 1998
- Compliance with Medical Treatment of GlaucomaJournal of Glaucoma, 1992